Catalyst Pharmaceuticals (CPRX) Other Working Capital Changes (2010 - 2026)
Catalyst Pharmaceuticals (CPRX) posted Other Working Capital Changes of -$106000.0 for Q1 2026, down 3.92% on a QoQ basis from -$102000.0 in Q4 2025, and down 9.28% year-over-year from -$116840.9 in Q1 2025.
Catalyst Pharmaceuticals (CPRX) Other Working Capital Changes (2010 - 2026) Analysis & Trends
Catalyst Pharmaceuticals' Other Working Capital Changes history runs 8 years deep, the most recent figure standing at -$106000.0 for Q1 2026.
- Quarterly Other Working Capital Changes fell 9.28% year-over-year to -$106000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$410000.0 (down 8.75% YoY) and the FY2025 annual result came in at -$401000.0, down 8.67% from the prior year.
- Other Working Capital Changes was -$106000.0 for Q1 2026 at Catalyst Pharmaceuticals, down from -$102000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $9.8 million in Q2 2024 and bottomed at -$7.0 million in Q1 2025.
- A 5-year average of $754764.7 and a median of $563000.0 in 2022 frame the typical range for Other Working Capital Changes.
- Peak annual rise in Other Working Capital Changes reached 0.0% in 2022, while the deepest fall reached 107.75% in 2022.
- Catalyst Pharmaceuticals' Other Working Capital Changes stood at -$78000.0 in 2022, then declined by 10.26% to -$86000.0 in 2023, then slipped by 9.3% to -$94000.0 in 2024, then declined by 8.51% to -$102000.0 in 2025, then decreased by 3.92% to -$106000.0 in 2026.
- Business Quant data shows CPRX's Other Working Capital Changes at -$106000.0 in Q1 2026, -$102000.0 in Q4 2025, and -$102000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Catalyst Pharmaceuticals | 3.85 Bn | 3.09 Bn | 134.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.45 Mn |
| Mar 31, 2026 | -2.45 Mn |
| Mar 31, 2026 | -2.45 Mn |
| Dec 31, 2025 | -6.91 Mn |
| Dec 31, 2025 | -6.91 Mn |
| Dec 31, 2025 | -6.91 Mn |
| Sep 30, 2025 | 6.70 Mn |
| Sep 30, 2025 | 6.70 Mn |
| Sep 30, 2025 | 6.70 Mn |
| Jun 30, 2025 | 7.41 Mn |
| Jun 30, 2025 | 7.41 Mn |
| Jun 30, 2025 | 7.41 Mn |
| Mar 31, 2025 | -7.02 Mn |
| Mar 31, 2025 | -7.02 Mn |
| Mar 31, 2025 | -7.02 Mn |
| Dec 31, 2024 | 2.66 Mn |
| Dec 31, 2024 | 2.66 Mn |
| Dec 31, 2024 | 2.66 Mn |
| Sep 30, 2024 | -5.17 Mn |
| Sep 30, 2024 | -5.17 Mn |